Yusuke Watanabe

Interventional Cardiologist, TAVI, MitraClip, Chief of structural heart program, Teikyo university school of medicine, Tokyo Japan

[Mitsuaki Sawano, MD, PhD, FACC @MitsuakiSawano]

🆕m3記事：TAVI後の軽度弁逆流、「問題なし」覆す9年データ　出ました‼️
「#JACCばらん」ダイジェストVol. 58――渡邊雄介先生（帝京大学）

🔗https://t.co/vnU7Z8eoM6

@Yusukeewatanabe @OhnoTuri @OCEAN_SHD @MitsuakiSawano @KenEjiri @Nobu0129 @SS_cardiol @JACCJournals @ACCinTouch @m3com_editors
#TAVR #PVR #StructuralHeart #ValveDurability #TAVI

[Yusuke Watanabe @Yusukeewatanabe]

@GingerWildheart I’m a big Japanese fun of you since 30 years, and this is 29x the pain….But I support your decision as a doctor and respect you!!!

[Yusuke Watanabe @Yusukeewatanabe]

Our new OCEAN registry paper is out in JACC: Cardiovascular Interventions. The editorial “Mild PVR After TAVR: Small Leak, Big OCEAN of Consequences” highlights the importance of addressing even mild PVR after TAVR.
#TAVR #StructuralHeart #JACC #SHD https://t.co/wMzosKQOJW

[Yusuke Watanabe @Yusukeewatanabe]

@taku_inohara 欧米は多枝病変が多く、なんらかの原因ですぐトロポニンが上がるのかなと。それでNSTE-ACSが多いのかと。日本はもともと悪くなくて、1枝詰まってSTEMIとなってくる人が多いのかなと思いました。

[CircInterventions @CircIntv]

With TAVR does the risk of the patient determine your use of cerebral emboli protection? Will the finding of this Research Letter change your utilization in the low to intermediate risk patient? @tavrkapadia @AlokeFinn @cvpath_md #TAVR #stroke #AHAJournals https://t.co/fVfoqjwQyC

[EuroIntervention @EuroInterventio]

The depth of the membranous septum varies significantly depending on the site of measurement. This issue should be taken into account when using this measure as a predictor for the onset of conduction abnormalities after TAVI. #EAPCI https://t.co/7SPRaAlqaW

[EuroIntervention @EuroInterventio]

In this trial of bifurcation PCI, the rates of malapposed and jailed struts around the bifurcation were not significantly different between POT with side branch dilatation and conventional kissing balloon inflation, and clinical events at 1 year were low. https://t.co/nF9H4qDDik

[NEJM @NEJM]

In this trial, patients with three-vessel coronary artery disease, PCI guided by assessment of fractional flow reserve was not noninferior to CABG with respect to the composite end point of death, myocardial infarction, stroke, or repeat revascularization. https://t.co/uYZGZWub0T

[Yusuke Watanabe @Yusukeewatanabe]

@didier_tchetche Thank you Didier. Fortunately we are safe, the terrible disaster occurred in the area of hot spring, Kanagawa prefecture the next to Tokyo.

[Davide Capodanno @DFCapodanno]

In #ATLANTIS, apixaban did not reduce a composite of thrombotic, ischemic or bleeding events compared with standard of care (i.e., VKA in patients with baseline indication to OAC, or DAPT/SAPT in those without). In the no-OAC stratum, the results remind me of GALILEO's. #ACC21

[Sanah Christopher @SanChris999]

#ACC21 Late breaking trials with the results of the ATLANTIS trial for results of pos-TAVR use of Eliquis

⭐️Eliquis 🚫 superior to antithrombotic mx
⭐️Non statistically significant ⬇️ subclinical valve thrombosis

[Yusuke Watanabe @Yusukeewatanabe]

分岐部病変の治療、KBTもPOTも良かったです。POTの有効なやり方とそうでないやり方について出せたと思います。

[EuroIntervention @EuroInterventio]

"Proximal Optimisation Technique Versus Final Kissing Balloon Inflation in Coronary Bifurcation Lesions: the Randomised, Multicenter PROPOT Trial" by Yusuke Watanabe et al. #EAPCI
https://t.co/heEbjZsrPd